キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/11/10 | 3,055 | 3,065 | 3,030 | 3,055 | +25 | +0.8% | 51,400 |
2023/11/09 | 3,005 | 3,050 | 2,990 | 3,030 | +10 | +0.3% | 103,300 |
2023/11/08 | 2,963 | 3,040 | 2,955 | 3,020 | +58 | +2% | 155,500 |
2023/11/07 | 2,908 | 3,030 | 2,907 | 2,962 | -198 | -6.3% | 216,700 |
2023/11/06 | 3,250 | 3,250 | 3,150 | 3,160 | -75 | -2.3% | 130,300 |
2023/11/02 | 3,285 | 3,315 | 3,215 | 3,235 | +20 | +0.6% | 58,100 |
2023/11/01 | 3,230 | 3,240 | 3,185 | 3,215 | +40 | +1.3% | 115,200 |
2023/10/31 | 3,095 | 3,200 | 3,095 | 3,175 | +85 | +2.8% | 100,200 |
2023/10/30 | 3,155 | 3,180 | 3,060 | 3,090 | -105 | -3.3% | 404,200 |
2023/10/27 | 3,135 | 3,195 | 3,120 | 3,195 | +75 | +2.4% | 68,000 |
2023/10/26 | 3,205 | 3,205 | 3,105 | 3,120 | -95 | -3% | 77,600 |
2023/10/25 | 3,250 | 3,260 | 3,215 | 3,215 | -25 | -0.8% | 67,400 |
2023/10/24 | 3,225 | 3,245 | 3,150 | 3,240 | +25 | +0.8% | 74,800 |
2023/10/23 | 3,205 | 3,240 | 3,200 | 3,215 | +5 | +0.2% | 55,000 |
2023/10/20 | 3,185 | 3,220 | 3,175 | 3,210 | +5 | +0.2% | 54,300 |
2023/10/19 | 3,155 | 3,230 | 3,155 | 3,205 | -10 | -0.3% | 40,900 |
2023/10/18 | 3,200 | 3,215 | 3,160 | 3,215 | +25 | +0.8% | 58,400 |
2023/10/17 | 3,210 | 3,250 | 3,170 | 3,190 | +5 | +0.2% | 45,300 |
2023/10/16 | 3,230 | 3,250 | 3,160 | 3,185 | -65 | -2% | 62,800 |
2023/10/13 | 3,320 | 3,320 | 3,245 | 3,250 | -100 | -3% | 70,300 |
2023/10/12 | 3,315 | 3,350 | 3,305 | 3,350 | +60 | +1.8% | 57,000 |
2023/10/11 | 3,280 | 3,315 | 3,270 | 3,290 | -20 | -0.6% | 53,100 |
2023/10/10 | 3,315 | 3,330 | 3,290 | 3,310 | +25 | +0.8% | 64,900 |
2023/10/06 | 3,260 | 3,315 | 3,260 | 3,285 | +30 | +0.9% | 51,100 |
2023/10/05 | 3,210 | 3,270 | 3,200 | 3,255 | +35 | +1.1% | 48,000 |
2023/10/04 | 3,215 | 3,245 | 3,195 | 3,220 | -55 | -1.7% | 77,100 |
2023/10/03 | 3,340 | 3,345 | 3,265 | 3,275 | -90 | -2.7% | 53,300 |
2023/10/02 | 3,420 | 3,430 | 3,360 | 3,365 | -25 | -0.7% | 69,900 |
2023/09/29 | 3,400 | 3,415 | 3,375 | 3,390 | ±0 | ±0% | 63,900 |
2023/09/28 | 3,400 | 3,430 | 3,370 | 3,390 | -60 | -1.7% | 48,700 |
2023/09/27 | 3,405 | 3,465 | 3,360 | 3,450 | +40 | +1.2% | 93,100 |
2023/09/26 | 3,420 | 3,440 | 3,390 | 3,410 | -25 | -0.7% | 48,400 |
2023/09/25 | 3,405 | 3,470 | 3,400 | 3,435 | +50 | +1.5% | 59,000 |
2023/09/22 | 3,390 | 3,410 | 3,350 | 3,385 | -15 | -0.4% | 54,400 |
2023/09/21 | 3,410 | 3,450 | 3,390 | 3,400 | +5 | +0.1% | 62,400 |
2023/09/20 | 3,475 | 3,485 | 3,395 | 3,395 | -65 | -1.9% | 88,300 |
2023/09/19 | 3,480 | 3,485 | 3,435 | 3,460 | -45 | -1.3% | 81,700 |
2023/09/15 | 3,495 | 3,535 | 3,465 | 3,505 | +40 | +1.2% | 108,400 |
2023/09/14 | 3,455 | 3,470 | 3,415 | 3,465 | +15 | +0.4% | 60,700 |
2023/09/13 | 3,435 | 3,475 | 3,425 | 3,450 | +15 | +0.4% | 64,900 |
2023/09/12 | 3,385 | 3,460 | 3,385 | 3,435 | +75 | +2.2% | 94,300 |
2023/09/11 | 3,410 | 3,435 | 3,340 | 3,360 | -40 | -1.2% | 51,000 |
2023/09/08 | 3,370 | 3,455 | 3,355 | 3,400 | +45 | +1.3% | 128,600 |
2023/09/07 | 3,390 | 3,395 | 3,350 | 3,355 | -45 | -1.3% | 38,600 |
2023/09/06 | 3,420 | 3,425 | 3,395 | 3,400 | -25 | -0.7% | 24,700 |
2023/09/05 | 3,440 | 3,445 | 3,395 | 3,425 | -20 | -0.6% | 55,300 |
2023/09/04 | 3,470 | 3,475 | 3,405 | 3,445 | -5 | -0.1% | 67,600 |
2023/09/01 | 3,390 | 3,470 | 3,390 | 3,450 | +40 | +1.2% | 75,100 |
2023/08/31 | 3,370 | 3,430 | 3,370 | 3,410 | +50 | +1.5% | 78,200 |
2023/08/30 | 3,285 | 3,390 | 3,285 | 3,360 | +15 | +0.4% | 111,000 |
451~
500
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム